KANO Shingo
(Professor/Division of Biosciences)
Department of Computational Biology and Medical Sciences/innovation Policy Research/ / Innovation Research in Advanced Medicine
Career Summary
2002: Ph.D., Department of Advanced Interdisciplinary Studies, Graduate School of Engineering, The University of Tokyo
2002-2013: CEO & President of Aphoenix, Inc.
2006-2008: Professor, Graduate School of Engineering Management (MOT Program), Shibaura Institute of Technology
2008-2013: Project Professor, Course of Intellectual Property in Bioscience, Department of Medical Genome Sciences, Graduate School of Frontier Sciences, The University of Tokyo
2009-2010: Visting Professor, MOT Research Centor, Research Organization for Advanced Engineering, Shibaura Institute of Technology
2009-2011: Visiting Professor, Centor for Advanced Science and Innovation, University of Osaka
2013-2015: Associate Professor, Lab. of Innovation Policy Research, Department of Medical Genome Sciences, Graduate School of Frontier Sciences, The University of Tokyo
2015-: Associate Professor, Lab. of Bio-Innovation Policy Research, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo
Educational Activities
Graduate School of Frontier Sciences:
1) Seminar of Intellectual Property in Biosciences I
2) Strategy in Biobusiness
3) Biotech Start-ups
Graduate School of Public Policy:
1) Social Design and Management
2) Policy for Medical Innovation
Research Activities
1. Analysis of intellectual property strategies in the biotechnology sector:
2. Measuring innovation in the advanced medical sector:
3. Innovation and regulation:
4. National innovation systems:
Literature
. Hifumi and S. Kano, "Reference Architecture-Based Analysis of Rule Coverage: Use Cases in Plasma Glucose Measurement and Cell Processing," in IEEE Access, vol. 14, pp. 26445-26458, 2026 2. Nageishi M and Kano S (2026) Bio-sampling alternative diagnostic imaging for telemedicine: a feasibility study of an AI-based throat camera for influenza. Front. Med. Eng. 3:1476892. 3. Matsuoka, T., & Kano, S. (2026). Impact of patent-granting differences between Japan and the United States on patent protection for medical methods: insights from genome editing patents. Expert Opinion on Therapeutic Patents, 36(2), 133–144. 4. Kitahara K. Kano S. Assessing rare disease understanding: a novel disease readiness level framework. Orphanet Journal of Rare Diseases 20, 628 (2025) 5. Sakaoka S. Kano S. Quantitative insights on artificial intelligence in the pharmaceutical industry: A patent-basis analysis of technological trends and key players. World Patent Information, Volume 82, 2025, 102381. 6. Tominaga S. Kano S. A Framework for Interdisciplinary Regulatory Approaches: A Case Study of VTOL and Roadable Aircraft in the Mobility Industry. European Journal of Risk Regulation., 2025, 1-17. 7. Kawai Y. Kano S. Expanding the concept of drug lifecycle management to chimeric antigen receptor T-cell products through product-patent linkage analysis. World Patent Information, Volume 81, 2025, 102357. 8. Itoh K. Kano S. International comparison of pandemic policies in the United States and Japan: Combination of all-hazards and single-hazard approaches as a realistic option to policymaking for public health emergency management system. International Journal of Disaster Risk Reduction, Volume 113, 2024, 104858. 9. Shiraiwa N. Kano S. Cost-effectiveness of multigene sequencing test and treatment for metastatic non-small cell lung cancer: A unique setting in the initial adoption phase in Japan allowing testing only after standard treatment. Heliyon, Volume 10, Issue 19, 2024, e37867. 10. Uchijima D. Kano S. International Comparison of Qualification Process for Medical Product Development Tools. Therapeutic Innovation & Regulatory Science, 58, 2024, 663-677. 11. Shinmura K. Kano S. Effects of Japan's past industry-academia collaboration reforms on university patent licensing income: the case of the University of Tokyo. International Journal of Technology Transfer and Commercialisation, Vol. 20, No. 4, 2024, 429-450.
Other Activities
Japan MOT Society, The Japan Society for Science Policy and Research Management, The Academic Association for Organizational Science, Business Model Association
Future Plan
To think about the required innovations for the 21st century and design the future, we focus on "the measurement of innovation in medical fields" and will develop a new scenario planning method in these fields. Intellectual property is the key to measure and analyze the industries, and we combine various social scientific methods for these purposes.
Messages to Students
Innovation research in social science is an interdisciplinary research, and all the researchers are required to have multiple viewpoints and interdisciplinary knowledge. Although there are no text books in this field, we will support problem finding and solving with our experience and broad research networks. Come join us in this challenge.